Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

UPL

₹550 -7.8 | 1.4%

Market Cap ₹46444 Cr.

Stock P/E -24.7

P/B 1.7

Current Price ₹550

Book Value ₹ 323.6

Face Value 2

52W High ₹599.5

Dividend Yield 0.17%

52W Low ₹ 429.7

UPL Research see more...

Overview Inc. Year: 1985Industry: Pesticides & Agrochemicals

UPL Limited is an totally India-based business enterprise that provides crop protection solutions. The Company is engaged in the enterprise of agrochemicals, industrial chemical substances, chemical intermediates and speciality chemical compounds. The Company's segments comprises Agro interest and Non Agro interest. The Agro interest section consists of the manufacture and advertising of conventional agrochemical products, seeds and different agricultural-associated merchandise. The Non Agro activity section includes manufacture and advertising and marketing of industrial chemical and other non-agricultural related merchandise. It gives fungicides, herbicides, insecticides, plant boom and regulators, rodenticides, industrial and nutrifeeds. The Company offers an integrated portfolio of each patented and post-patent agricultural solutions for various arable and distinctiveness crops, along with biological, crop protection, seed remedy and post-harvest solutions covering the complete crop cost chain.

Read More..

UPL Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

UPL Quarterly Results

#(Fig in Cr.) Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 10821 12507 13679 16569 8963 10170 9887 14078 9067 11090
Other Income 73 78 115 211 101 105 151 126 98 111
Total Income 10894 12585 13794 16780 9064 10275 10038 14204 9165 11201
Total Expenditure 8675 10063 10795 13847 7690 8845 9794 12230 7966 9738
Operating Profit 2219 2522 2999 2933 1374 1430 244 1974 1199 1463
Interest 519 644 894 906 700 871 1191 1090 913 1070
Depreciation 588 608 624 727 636 657 676 794 660 697
Exceptional Income / Expenses -78 -43 -20 -29 -43 -87 -17 -105 -49 -8
Profit Before Tax 1034 1227 1461 1271 -5 -185 -1640 -15 -423 -312
Provision for Tax 59 231 135 311 -164 -96 -59 110 72 138
Profit After Tax 975 996 1326 960 159 -89 -1581 -125 -495 -450
Adjustments -98 -182 -239 -168 7 -100 364 165 111 7
Profit After Adjustments 877 814 1087 792 166 -189 -1217 40 -384 -443
Adjusted Earnings Per Share 11.2 10.4 13.9 10.1 2.1 -2.4 -15.6 0.5 -4.9 -5.7

UPL Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 10771 12091 14048 16312 17378 21837 35756 38694 46240 53576 43098 44122
Other Income 184 206 316 495 429 332 266 259 296 477 483 486
Total Income 10954 12296 14364 16807 17807 22169 36022 38953 46536 54053 43581 44608
Total Expenditure 8768 9827 11653 13331 13880 18080 28983 30343 36726 43380 38559 39728
Operating Profit 2186 2470 2711 3476 3927 4089 7039 8610 9810 10673 5022 4880
Interest 537 632 704 782 791 998 1643 2060 2295 2963 3852 4264
Depreciation 407 425 676 672 675 881 2012 2173 2359 2547 2763 2827
Exceptional Income / Expenses -85 -3 -129 -81 -63 -451 -623 -238 -324 -170 -252 -179
Profit Before Tax 1157 1410 1117 1922 2305 1773 2764 4181 4966 5150 -2087 -2390
Provision for Tax 222 244 165 189 275 198 586 686 529 736 -209 261
Profit After Tax 935 1166 952 1733 2030 1575 2178 3495 4437 4414 -1878 -2651
Adjustments 15 -22 -12 -6 -8 -84 -402 -624 -811 -844 678 647
Profit After Adjustments 950 1144 940 1727 2022 1491 1776 2871 3626 3570 -1200 -2004
Adjusted Earnings Per Share 14.2 17.1 14 21.8 25.4 18.7 22.3 36 45.5 45.7 -15.3 -25.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -20% 4% 15% 15%
Operating Profit CAGR -53% -16% 4% 9%
PAT CAGR -143% NAN% NAN% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 5% -9% 1% 9%
ROE Average -7% 11% 14% 19%
ROCE Average 3% 11% 11% 15%

UPL Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 5247 5860 5889 7397 9169 14715 19283 20887 21675 26858 24807
Minority's Interest 172 44 44 33 19 3454 3312 3693 4647 5585 4913
Borrowings 2254 1694 2266 5350 5873 26382 27371 22141 24591 23130 26996
Other Non-Current Liabilities 445 692 112 -97 -189 1622 1779 2417 1714 1306 374
Total Current Liabilities 4640 5993 8168 7028 7642 16262 16685 19627 27976 29037 26861
Total Liabilities 12759 14284 16479 19711 22514 62435 68430 68765 80603 85916 83951
Fixed Assets 3821 4031 3862 4071 4437 32149 35322 34765 36193 38713 39056
Other Non-Current Assets 1387 1765 1410 1942 3053 3564 3866 3930 4682 5175 5567
Total Current Assets 7552 8489 11183 13658 15004 26696 29191 30015 39680 41988 39299
Total Assets 12759 14284 16479 19711 22514 62435 68430 68765 80603 85916 83951

UPL Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 1685 1018 1046 1177 2877 2859 2826 6724 4797 5797 5967
Cash Flow from Operating Activities 1441 1409 1396 2585 2839 2356 8739 7212 6496 7751 1822
Cash Flow from Investing Activities -418 -331 -1719 -999 -2093 -30920 -2643 -2101 -3819 -1490 -2478
Cash Flow from Financing Activities -1680 -991 469 140 -801 28894 -2175 -6713 -1921 -6227 164
Net Cash Inflow / Outflow -657 86 146 1726 -55 330 3921 -1602 756 34 -492
Closing Cash & Cash Equivalent 1018 973 1177 2880 2859 2827 6724 4797 5797 5967 5943

UPL Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 14.17 17.07 13.98 21.83 25.35 18.69 22.27 36 45.46 45.66 -15.35
CEPS(Rs) 20.02 23.74 24.21 30.45 33.92 30.79 52.54 71.07 85.21 89.02 11.32
DPS(Rs) 2.56 3.21 3.21 4.49 5.13 5.13 5.77 9.62 9.62 9.62 0.96
Book NAV/Share(Rs) 78.29 87.43 31.08 92.6 114.96 184.5 204.34 224.44 271.52 343.23 317
Core EBITDA Margin(%) 18.59 18.72 16.7 17.87 16.41 14.58 16.15 18.32 17.38 15.82 8.54
EBIT Margin(%) 15.73 16.89 12.7 16.21 14.53 10.75 10.51 13.69 13.26 12.59 3.32
Pre Tax Margin(%) 10.74 11.67 7.79 11.52 10.82 6.88 6.59 9.17 9.07 7.99 -3.93
PAT Margin (%) 8.68 9.65 6.64 10.39 9.53 6.11 5.19 7.67 8.1 6.85 -3.53
Cash Profit Margin (%) 12.46 13.16 11.35 14.42 12.69 9.53 9.99 12.43 12.41 10.8 1.66
ROA(%) 7.45 8.63 6.19 9.58 9.62 3.71 3.33 5.09 5.94 5.3 -2.21
ROE(%) 18.9 21 23.95 36.86 24.63 13.19 14.05 20.44 22.43 18.2 -7.28
ROCE(%) 19.42 23.03 17.95 21.71 20.94 9.29 9.6 13.47 15.26 15.7 3.24
Receivable days 99.86 105.68 113.15 117.68 100.3 125.56 102.45 96.14 91.58 95 118.71
Inventory Days 77.07 81.78 85.56 86.91 74.46 96.79 73.9 69.15 75 76.63 91.88
Payable days 160.72 179.08 192.89 206.15 237.35 259.79 195.52 219.73 242.35 228.56 248.1
PER(x) 8.31 16.57 21.85 21.26 18.36 32.7 14.06 17.11 16.24 15.07 0
Price/Book(x) 1.5 3.23 9.83 5.01 4.05 3.31 1.53 2.74 2.72 2 1.38
Dividend Yield(%) 2.17 1.13 1.05 0.96 1.1 0.84 1.84 1.56 1.3 1.39 0.22
EV/Net Sales(x) 0.95 1.76 1.75 2.46 2.35 3.44 1.31 1.76 1.77 1.38 1.38
EV/Core EBITDA(x) 4.67 8.59 9.08 11.57 10.41 18.35 6.67 7.9 8.32 6.91 11.86
Net Sales Growth(%) 17.26 12.25 16.19 16.12 6.54 25.66 63.74 8.22 19.5 15.87 -19.56
EBIT Growth(%) 23.4 20.56 -10.83 48.49 14.5 -10.5 59.04 41.62 16.34 11.73 -78.24
PAT Growth(%) 26.21 24.76 -18.38 82.04 17.14 -22.41 38.29 60.47 26.95 -0.52 -142.55
EPS Growth(%) 26.62 20.45 -18.1 56.17 16.14 -26.26 19.11 61.66 26.3 0.42 -133.61
Debt/Equity(x) 0.64 0.56 2.52 0.86 0.72 1.98 1.49 1.14 1.33 0.97 1.27
Current Ratio(x) 1.63 1.42 1.37 1.94 1.96 1.64 1.75 1.53 1.42 1.45 1.46
Quick Ratio(x) 1.09 0.93 0.91 1.35 1.37 1.08 1.28 1.05 0.95 0.96 0.99
Interest Cover(x) 3.15 3.23 2.59 3.46 3.91 2.78 2.68 3.03 3.16 2.74 0.46
Total Debt/Mcap(x) 0.42 0.17 0.26 0.17 0.18 0.6 1.15 0.48 0.49 0.48 0.92

UPL Shareholding Pattern

# Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Promoter 28.96 30.74 32.52 32.52 32.52 32.52 32.52 32.52 32.52 33.5
FII 35.56 37.17 38.68 37.95 33.56 34.38 33.64 34.51 34.22 32.52
DII 17.2 16.21 14.41 19.28 17.27 16.82 15.32 15.74 17.65 18.71
Public 18.28 10.35 10.46 10.25 12.62 12.97 15.21 13.92 12.3 12.33
Others 0 5.52 3.94 0 4.03 3.31 3.31 3.31 3.32 2.94
Total 100 100 100 100 100 100 100 100 100 100

Pros

Cons

  • Promoter holding is low: 33.5%.
  • Company has a low return on equity of 11% over the last 3 years.
  • Debtor days have increased from 228.56 to 248.1days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

UPL News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....